These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 11197067

  • 1. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
    Miyahara T, Gomyo S, Ueda Y, Ohyama Y, Sigeno C, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Yamamoto M, Sakuma T, Nemoto N.
    Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
    [Abstract] [Full Text] [Related]

  • 2. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
    Honda A, Nakashima N, Shida Y, Mori Y, Nagata A, Ishizuka S.
    Biochem J; 1993 Oct 15; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
    [Abstract] [Full Text] [Related]

  • 3. 1alpha,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1alpha,25-dihydroxyvitamin D3.
    Miyamoto Y, Shinki T, Yamamoto K, Ohyama Y, Iwasaki H, Hosotani R, Kasama T, Takayama H, Yamada S, Suda T.
    J Biol Chem; 1997 May 30; 272(22):14115-9. PubMed ID: 9162038
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
    Miyahara T, Harada M, Kozakai A, Matsumoto M, Hashimoto K, Inoue H, Yoda K, Nakatsu T, Kajita S, Yamazaki R, Higuchi S, Kozuka H, Nemoto N.
    J Nutr Sci Vitaminol (Tokyo); 1999 Jun 30; 45(3):239-49. PubMed ID: 10524344
    [Abstract] [Full Text] [Related]

  • 5. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T, Simoura T, Osahune N, Uchida Y, Sakuma T, Nemoto N, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Chiba H, Iba K, Sawada N.
    Calcif Tissue Int; 2002 Jun 30; 70(6):488-95. PubMed ID: 12016462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
    Honda A, Nakashima N, Mori Y, Katsumata T, Ishizuka S.
    J Steroid Biochem Mol Biol; 1992 Jan 30; 41(1):109-12. PubMed ID: 1310414
    [Abstract] [Full Text] [Related]

  • 8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 30; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria.
    Harada M, Miyahara T, Kajita-Kondo S, Kozakai A, Higuchi S, Otomo S, Kozuka H.
    Res Commun Mol Pathol Pharmacol; 1994 Nov 30; 86(2):183-93. PubMed ID: 7881867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
    Imanishi Y, Inaba M, Seki H, Koyama H, Nishizawa Y, Morii H, Otani S.
    J Steroid Biochem Mol Biol; 1999 Nov 30; 70(4-6):243-8. PubMed ID: 10622414
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.
    Sakaki T, Sawada N, Komai K, Shiozawa S, Yamada S, Yamamoto K, Ohyama Y, Inouye K.
    Eur J Biochem; 2000 Oct 30; 267(20):6158-65. PubMed ID: 11012668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
    Inaba M, Okuno S, Inoue A, Nishizawa Y, Morii H, DeLuca HF.
    Arch Biochem Biophys; 1989 Jan 30; 268(1):35-9. PubMed ID: 2463789
    [Abstract] [Full Text] [Related]

  • 20. Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones.
    Siu-Caldera ML, Zou L, Ehrlich MG, Schwartz ER, Ishizuka S, Reddy GS.
    Endocrinology; 1995 Oct 30; 136(10):4195-203. PubMed ID: 7664636
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.